Compare LQDA & FSUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LQDA | FSUN |
|---|---|---|
| Founded | 2004 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 966.0M |
| IPO Year | 2018 | N/A |
| Metric | LQDA | FSUN |
|---|---|---|
| Price | $33.47 | $37.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 3 |
| Target Price | $37.40 | ★ $45.67 |
| AVG Volume (30 Days) | ★ 1.7M | 143.0K |
| Earning Date | 11-03-2025 | 01-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.52 |
| EPS | N/A | ★ 3.16 |
| Revenue | $69,216,000.00 | ★ $384,497,000.00 |
| Revenue This Year | $904.79 | $18.64 |
| Revenue Next Year | $188.25 | $49.01 |
| P/E Ratio | ★ N/A | $11.95 |
| Revenue Growth | ★ 343.41 | 10.48 |
| 52 Week Low | $10.37 | $29.95 |
| 52 Week High | $35.54 | $45.32 |
| Indicator | LQDA | FSUN |
|---|---|---|
| Relative Strength Index (RSI) | 62.18 | 67.84 |
| Support Level | $32.11 | $33.41 |
| Resistance Level | $35.54 | $36.15 |
| Average True Range (ATR) | 1.60 | 0.95 |
| MACD | -0.11 | 0.66 |
| Stochastic Oscillator | 72.94 | 94.50 |
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
Firstsun Capital Bancorp is the financial holding company. It provides a full range of deposit, lending, treasury management, wealth management, and online banking products and services. The company operates in two segments - Banking operations and mortgage operations, the majority of which are generated by the banking operations segment. The Banking segment originates loans and provides deposits and fee based services to consumer, business, and mortgage lending customers. Products offered include a full range of commercial and consumer banking and financial services. The Mortgage Operations segment originates, sells, services, and manages market risk from changes in interest rates on one-to-four family residential mortgage loans.